SCHEMBL24890451

SCHEMBL24890451

BC(=O)c1c(OC)cc(C)cc1OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.47
ALDH1A1 P00352 1/20 0.47
CYP3A4 P08684 3/20 0.44
ERN1 O75460 1/20 0.44
CNR2 P34972 2/20 0.42
POLB P06746 2/20 0.41
RECQL P46063 2/20 0.41
GAA P10253 1/20 0.41
USP2 O75604 1/20 0.40
MAPK1 P28482 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
CA2 P00918 3/20 0.38
CA12 O43570 2/20 0.38
CA1 P00915 2/20 0.38
CA7 P43166 2/20 0.38
CA9 Q16790 2/20 0.38
CA14 Q9ULX7 2/20 0.38
PKM P14618 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1004368 0.83 ACHE (0.48) ACHESMN1; SMN2ALDH1A1CYP3A4ERN1
SCHEMBL6745474 0.80 CA2 (0.59) ACHESMN1; SMN2ALDH1A1CYP3A4ERN1
SCHEMBL12248741 0.80 CYP3A4 (0.60) ACHESMN1; SMN2ALDH1A1CYP3A4ERN1
SCHEMBL11516098 0.78 ACHE (0.48) ACHESMN1; SMN2ALDH1A1CYP3A4ERN1
SCHEMBL8330318 0.78 POLB (0.53) ACHESMN1; SMN2ALDH1A1CYP3A4ERN1
SCHEMBL21939513 0.75 ALDH1A1 (0.49) ACHESMN1; SMN2ALDH1A1CYP3A4ERN1
SCHEMBL16644713 0.75 CYP3A4 (0.55) ACHESMN1; SMN2ALDH1A1CYP3A4ERN1
SCHEMBL4408095 0.74 CYP3A4 (0.68) ACHESMN1; SMN2ALDH1A1CYP3A4ERN1
SCHEMBL8894531 0.74 ACHE (0.43) ACHESMN1; SMN2ALDH1A1CYP3A4ERN1
SCHEMBL12248740 0.74 HPGDS (0.47) ACHESMN1; SMN2ALDH1A1CYP3A4ERN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230016922-A1 VISIBLE-LIGHT MEDIATED ORGANOPHOTOREDOX CATALYTIC DEUTERATION OF AROMATIC AND ALIPHATIC ALDEHYDES NATIONAL INSTITUTES OF HEALTH 2023-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230016922-A1 VISIBLE-LIGHT MEDIATED ORGANOPHOTOREDOX CATALYTIC DEUTERATION OF AROMATIC AND ALIPHATIC ALDEHYDES AOX1, TDO2, TALDO1 ACHE 1514/4885SMN1; SMN2 3267/4885ALDH1A1 34/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.